- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 278
FogPharma advances to $66m series B
6 Dimensions Capital led a round for the miniprotein drug developer, founded by Harvard researcher Gregory Verdine.
May 18, 2018FogPharma advances to $66m series B
6 Dimensions Capital led a round for the miniprotein drug developer that included Nan Fung, GV and WuXi AppTec Corporate Ventures.
May 17, 2018Ladder extends series B to $40m
Allianz Life Ventures and Northwestern Mutual Future Ventures have invested $10m in the online life insurance provider, taking its total funding to $54m.
May 17, 2018Vesper vets corporates for $23m series B
American Family Insurance led the advanced microphone developer's latest round, which included Shure, Synaptics, Baidu, Bose and Amazon Alexa Fund.
May 17, 2018FAW invests $260m to drive Byton series B
Smart car developer Byton has raised $260m from carmaker FAW, as part of what is now expected to be a $500m round.
May 17, 2018BIVF tunes into Acousia for series B
Acousia has raised $11.8m from backers including Boehringer Ingelheim Venture Fund to advance therapies for inner-ear impairments into the clinic.
May 17, 2018Moloco milks investors for $11m
The mobile advertising technology provider raised the cash in a series B round co-led by Samsung Ventures that will fund product development.
May 16, 2018Nohla nails series B to raise $45m
Celgene was among the investors helping the cancer cell-therapy developer increase its total funding to approximately $110m.
May 16, 2018Qventus quickes pace to $30m series B
NewYork-Presbyterian Hospital was among the backers in a round that took the healthcare planning platform's total funding to more than $43m.
May 15, 2018About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


